✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Hydroxyzine Hydrochloride is a drug marketed by Altana, Am Regent, Baxter Hlthcare, Dr Reddys, Fresenius Kabi Usa, Hospira, Pharmafair, Smith And Nephew, Solopak, Watson Labs, Wyeth Ayerst, Akorn, Alpharma Us Pharms, Anima, Kv Pharm, Lannett Co Inc, Pai Holdings Pharm, Torrent, Wockhardt Bio Ag, Able, Actavis Elizabeth, Amneal Pharm, Aurobindo Pharma Ltd, Biopharm, Epic Pharma Llc, Halsey, Heritage Pharma, Hetero Labs Ltd Iii, Invagen Pharms, Ivax Pharms, Kvk Tech, Mutual Pharm, Northstar Hlthcare, Nuvo Pharms Inc, Pliva, Prinston Inc, Purepac Pharm, Quantum Pharmics, Rising, Sandoz, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, and Usl Pharma. and is included in ninety-nine NDAs.
The generic ingredient in HYDROXYZINE HYDROCHLORIDE is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.
A generic version of HYDROXYZINE HYDROCHLORIDE was approved as hydroxyzine hydrochloride by WOCKHARDT BIO AG on April 12th, 1982.
Recent Clinical Trials for HYDROXYZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Mongi Slim Hospital||N/A|
|Assiut University||Phase 4|
|Istanbul Medeniyet University||Phase 4|